<DOC>
	<DOCNO>NCT02074267</DOCNO>
	<brief_summary>The purpose study assess efficacy Gabapentin ( Carbatin &amp; Neurontin ) patient neuropathy pain .</brief_summary>
	<brief_title>Clinical Study Assessment Efficacy Gabapentin ( Carbatin Neurontin ) Patients With Neuropathy Pain</brief_title>
	<detailed_description />
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Subjects diagnose disease neuropathy pain arise diabetic peripheral neuropathy , postherpetic neuralgia , traumatic/surgical nerve injury , incomplete spinal cord injury , trigeminal neuralgia mean weekly pain score least 4 100mm visual analog scale ( VAS ) ShortForm McGill Pain Questionnaire ( SFMPQ ) complete screen / baseline period randomization . Additional diseasespecific inclusion criterion list Table 1 . Subjects must 20 year age old . Subjects pregnant , lactate childbearing potential use effective contraceptive . Subjects clinically significant unstable medical psychiatric condition . Subjects know hypersensitivity Gabapentin . Serum creatinine &gt; 1.5 time upper limit normal Subjects receive nerve block acupuncture pain relief within four week screen / baseline period . Subjects presence chronic pain target pain study ( unless chronic pain different body region target pain intensity great target pain ) . Subjects receive nondrug therapy special procedure relief target pain within two week baseline visit . Subjects use follow agent within 30 day prior screen : antidepressant , opioids , anticonvulsant , local anaesthetic injection investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>